Concepedia

Carl P. Decicco

CP

96

Publications

5K

Citations

39

H-Index

1985

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Wilmington University

Experimental Station

DuPont (United States)

Bristol-Myers Squibb (Germany)

Carl P. Decicco is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1985–2025

96

Publications

96

Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS Family

Ilgar Abbaszade, Rui‐Qin Liu, Fude Yang et al. · Journal of Biological Chemistry · 1999 · 486 citations · Full text

Aggrecan Protects Cartilage Collagen from Proteolytic Cleavage

Michael A. Pratta, Wenqing Yao, Carl P. Decicco et al. · Journal of Biological Chemistry · 2003 · 282 citations · Full text

Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor

Kevin W. Gillman, John E. Starrett, Michael F. Parker et al. · ACS Medicinal Chemistry Letters · 2010 · 183 citations

, , +19

Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase

Elizabeth C. Arner, Clare Hughes, Carl P. Decicco et al. · Osteoarthritis and Cartilage · 1998 · 138 citations · Full text

, , +4

Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α

Percy H. Carter, Peggy Scherle, Jodi A. Muckelbauer et al. · Proceedings of the National Academy of Sciences · 2001 · 136 citations · Full text

, , +20

Rows per page

1–5 of 96